Michael McCully

Company: Gate Neurosciences

Job title: Co-Founder, President & Chief Executive Officer

Seminars:

Unlocking Event-Driven Pharmacology: New Translational Data Supporting Clinical Development of the ‘Stinels’, a Novel Class of NMDAR Modulators 1:30 pm

Enhancing synaptic function through direct NMDAR-mediated mechanism shows rapid and durable anti-depressant effect Using translational tools to predict and test dose model, confirmed through clinical qEEG biomarkers now with a second molecule in the classRead more

day: Conference Day One